Reduced serum cholecystokinin and increase in body fat during oral contraception

Contraception

Volumn 53, Issue 2, 1996, Pages 109-113

  Lindén Hirschberg, Angelica ^a   Byström, Birgitta ^a   Carlström, Kjell ^a   Von Schoultz, Bo ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

appetite; body fat; cholecystokinin; oral contraceptives; weight

Indexed keywords

CHOLECYSTOKININ; DESOGESTREL; ETHINYLESTRADIOL; GASTRIN; GASTROINTESTINAL HORMONE; GESTAGEN; GLUCOSE; INSULIN; ORAL CONTRACEPTIVE AGENT; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TESTOSTERONE; TRIACYLGLYCEROL;

ADIPOSE TISSUE; APPETITE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CHOLECYSTOKININ BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG EFFECT; FEMALE; FOOD INTAKE; HUMAN; HUNGER; LIPOLYSIS; METABOLIC PARAMETERS; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; SATIETY;

EID: 0343844334     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/0010-7824(95)00265-0     Document Type: Article

References (24)

1. Mishell DR Jr. Adverse effects of oral contraceptives. In: Brosens I, ed. New Considerations in Oral Contraception. New York: Biomedical Information Corp Publications, 1982:77-80.
2. Guillebaud J. Practical prescribing of the combined oral contraceptive pill. In: Filshie M, Guillebaud J, eds. Contraception: Science and Practice. London: Butterworths, 1989:11-38.
3. Amatayakul K, Sivasomboon B, Thanangkul O. A study of the mechanism of weight gain in medroxyprogesterone acetate users. Contraception 1980;22:605-22.
4. Wade GN. Sex hormones, regulatory behaviors, and body weight. In: Rosenblatt JS, Hinde RA, Shaw E, Beer CG, eds. Advances in the Study of Behavior, vol 6. New York: Academic Press, 1976:201-79.
5. Mutt V. Secretin and Cholecystokinin. San Diego: Academic Press, 1988:270-320. (Mutt V. Advances in metabolic disorders, gastrointestinal hormones II; vol 11).
6. Kissileff HR, Pi-Sunyer FX, Thornton J, Smith GP. C-terminal octapeptide of cholecystokinin decreases food intake in man. Am J Clin Nutr 1981;34:154-60.
7. Smith GP, Jerome C, Cushin BJ, Eterno R, Simansky KJ. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 1981;213:1036-7.
8. Della-Fera MA, Baue CA. Cholecystokinin octapeptide: continuous picomole injections into the cerebral ventricles of sheep suppress feeding. Science 1979;206:471-3.
9. Geracioti JTD, Liddle RA. Impaired cholecystokinin secretion in bulimia nervosa. N Engl J Med 1988;319: 683-8.
10. Lindén Hirschberg A, Lindholm C, Carlström K, von Schoultz B. Reduced serum cholecystokinin response to food intake in female athletes. Metabolism 1994;43: 217-22.
11. Karlsson R, Lindén A, von Schoultz B. Suppression of 24-hour cholecystokinin secretion by oral contraceptives. Am J Obstet Gynecol 1992;167:58-9.
12. Gillmer MDG. Metabolic effects of combined oral contraceptives. In: Filshie M, Guillebaud J, eds. Contraception: Science and Practice. London: Butterworths, 1989: 11-38.
13. Hermansen L, von Döbeln W. Body fat and skin-fold measurements. Scand J Clin Lab Invest 1971;27:315-9.
14. Pardridge NM. Serum bioavailability of sex steroid hormones. Clinics Endocrinol Metabol 1986;15:219-78.
15. Södergård R, Bäckström T, Shanbhag V, Carstensen H. Calculation of free and bound fraction of testosterone and estradiol-17β to plasma proteins at body temperature. J Steroid Biochem 1982;18:801-4.
16. Wade GN, Gray JM. Gonadal effects on food intake and adiposity: a metabolic hypothesis. Physiol Behav 1979; 22:583-93.
17. Lindén A, Uvnäs-Moberg K, Forsberg G, Bednar I, Eneroth P, Södersten P. Involvement of cholecystokinin in food intake: II. Lactational hyperphagia in the rat. J Neuroendocrinol 1990;2:791-6.
18. Lindén A, Uvnäs-Moberg K, Forsberg G, Bednar I, Södersten P. Involvement of cholecystokinin in food intake: III. Oestradiol potentiates the inhibitory effect of cholecystokinin octapeptide on food intake in ovariectomized rats. J Neuroendocrinol 1990;2:797-801.
19. Crawley JN, Beinfeld MC. Rapid development of tolerance to the behavioural actions of cholecystokinin. Nature 1983;302:703-6.
20. Richter WO, Schwandt P. Cholecystokinin 1-21 stimulates lipolysis in human adipose tissue. Horm Metabol Res 1989;21:216-7.
21. Rushakoff RJ, Goldfine ID, Carter JC, Liddle RA. Physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans. J Clin Endocrinol Metab 1987;65:395-401.
22. Rushakoff RA, Goldfine ID, Beccaria LJ, Mathur A, Brand RJ, Liddle RA. Reduced postprandial cholecystokinin (CCK) secretion in patients with non-insulin-dependent diabetes mellitus: Evidence for a role for CCK in regulating postprandial hyperglycemia. J Clin Endocrinol Metab 1993;76:489-3.
23. Stege R, Fröhlander N, Carlström K, Pousette Å, von Schoultz B. Steroid-sensitive proteins, growth hormone and somatomedin C in prostatic cancer: Effects of parenteral and oral estrogen therapy. Prostate 1987;10: 333-8.
24. Mooradian AD, Morley JE, Korenman SG. Biological actions of androgens. Endocrin Rev 1987;8:1-28.